Abhinav Vasudevan

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 34

Top Topics

Magnetic Resonance

Ulcerative Colitis

Systematic Review

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

JGH open : an open access journal of gastroenterology and hepatology

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Abhinav Vasudevan, Danny Con, Daniel R Van Langenberg
Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply. Alimentary pharmacology & therapeutics 59 (6) (2024)
Anuj Bohra, Nicholas Batt, Krishneel Dutt, Pavel Sluka, Olga Niewiadomski, Abhinav Vasudevan, Daniel R Van Langenberg
Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment? Inflammatory bowel diseases (2024)
Krishneel Dutt, Abhinav Vasudevan
Editorial: Exclusive enteral nutrition: Positioning in the ever-growing landscape of inflammatory bowel disease therapy. Alimentary pharmacology & therapeutics (2024)
Krishneel Dutt, Abhinav Vasudevan
Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Bridgette Andrew, Steven Trinh, Annie Zhou, Abhinav Vasudevan, Ashish Srinivasan
Anal Cancer in Crohn's Disease: The Need to Optimize Treatment and Improve Surveillance. The American journal of gastroenterology 119 (2) (2024)
Abhinav Vasudevan, Danny Con, Daniel R Van Langenberg
Letter: Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply. Alimentary pharmacology & therapeutics 59 (8) (2024)
Krishneel Dutt, Abhinav Vasudevan
Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Krishneel Dutt, Abhinav Vasudevan
Editorial: Exclusive enteral nutrition: Positioning in the ever-growing landscape of inflammatory bowel disease therapy. Alimentary pharmacology & therapeutics 60 (2) (2024)
Abhinav Vasudevan, Danny Con, Daniel R Van Langenberg
Letter: Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply. Alimentary pharmacology & therapeutics 59 (8) (2024)
Abhinav Vasudevan, Danny Con, Daniel R Van Langenberg
Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply. Alimentary pharmacology & therapeutics 59 (6) (2024)
Krishneel Dutt, Abhinav Vasudevan
Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Anuj Bohra, Nicholas Batt, Krishneel Dutt, Pavel Sluka, Olga Niewiadomski, Abhinav Vasudevan, Daniel R Van Langenberg
Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment? Inflammatory bowel diseases (2024)
Anuj Bohra, Nicholas Batt, Krishneel Dutt, Pavel Sluka, Olga Niewiadomski, Abhinav Vasudevan, Daniel R Van Langenberg
Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment? Inflammatory bowel diseases (2024)
Bridgette Andrew, Steven Trinh, Annie Zhou, Abhinav Vasudevan, Ashish Srinivasan
Anal Cancer in Crohn's Disease: The Need to Optimize Treatment and Improve Surveillance. The American journal of gastroenterology 119 (2) (2024)
Krishneel Dutt, Abhinav Vasudevan
Editorial: Exclusive enteral nutrition: Positioning in the ever-growing landscape of inflammatory bowel disease therapy. Alimentary pharmacology & therapeutics 60 (2) (2024)
Abhinav Vasudevan, Danny Con, Peter De Cruz, Miles Patrick Sparrow, Antony B Friedman, Mayur Garg, Soleiman Kashkooli, Peter R Gibson, Daniel R Van Langenberg
Clinical trial: Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study). Alimentary pharmacology & therapeutics (2023)
Anuj Bohra, Ghada Mohamed, Abhinav Vasudevan, Diana Lewis, Daniel R Van Langenberg, Jonathan P Segal
The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis. Biomedicines 11 (5) (2023)
Abhinav Vasudevan, Vivek Tharayil, Laura H Raffals, David H Bruining, Michelle Becker, Mohammad Hassan Murad, Edward V Loftus
Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Anuj Bohra, Abhinav Vasudevan, Numan Kutaiba, Daniel Ross Van Langenberg
Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn's Disease: Are We There Yet? Diagnostics (Basel, Switzerland) 13 (6) (2023)
Bridgette Andrew, Annie Zhou, Steven Trinh, Ashish Srinivasan, Abhinav Vasudevan
Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease-More thought is needed. Alimentary pharmacology & therapeutics 58 (8) (2023)
Anuj Bohra, Abhinav Vasudevan, Numan Kutaiba, Daniel Ross Van Langenberg
Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn's Disease: Are We There Yet? Diagnostics (Basel, Switzerland) 13 (6) (2023)
Anuj Bohra, Diana Lewis, Jonathan P Segal, Abhinav Vasudevan, Daniel R Van Langenberg, Olga D Niewiadomski
Utility of panenteric capsule endoscopy for the detection of small-bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study. JGH open : an open access journal of gastroenterology and hepatology 7 (12) (2023)
Bridgette Andrew, Ashish Srinivasan, Annie Zhou, Abhinav Vasudevan
Letter: Elderly onset inflammatory bowel disease-Treat to target approach is still warranted. Alimentary pharmacology & therapeutics 58 (5) (2023)
Anuj Bohra, Diana Lewis, Jonathan P Segal, Abhinav Vasudevan, Daniel R Van Langenberg, Olga D Niewiadomski
Utility of panenteric capsule endoscopy for the detection of small-bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study. JGH open : an open access journal of gastroenterology and hepatology 7 (12) (2023)
Steven Trinh, Bridgette Andrew, Abhinav Vasudevan
6-mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol. Journal of Crohn's & colitis (2023)
Abhinav Vasudevan, Daniel R Van Langenberg
Editorial: delving into the natural history of Crohn's disease and the impact of medical therapy. Alimentary pharmacology & therapeutics 55 (1) (2022)
Anuj Bohra, Abhinav Vasudevan, Numan Kutaiba, Daniel R Van Langenberg
Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn's Disease. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Abhinav Vasudevan, Nina Parthasarathy, Danny Con, Steven Nicolaides, Ross Apostolov, Ayushi Chauhan, Maria Bishara, Raphael P Luber, Neetima Joshi, Anna Wan, James A Rickard, Tony Long, Declan Connoley, Miles Patrick Sparrow, Peter R Gibson, Daniel R Van Langenberg
Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease. Alimentary pharmacology & therapeutics 52 (7) (2020)
Abhinav Vasudevan, Daniel R Van Langenberg
Editorial: direct costs are only the tip of the iceberg in inflammatory bowel disease. Alimentary pharmacology & therapeutics 52 (5) (2020)
Abhinav Vasudevan, Danny Con, Steven Nicolaides, Daniel R Van Langenberg
Editorial: methotrexate vs azathioprine-do differential rates of discontinuation settle the debate? Authors' reply. Alimentary pharmacology & therapeutics 52 (9) (2020)
Abhinav Vasudevan, Asiri Arachchi, Cian Scanlon, Jarrod Greenhalgh, Daniel R Van Langenberg
A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomy. Therapeutic advances in chronic disease 10 (2019)
Daniel R Van Langenberg, Abhinav Vasudevan
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Alimentary pharmacology & therapeutics 48 (9) (2019)
Abhinav Vasudevan, Zaid S Ardalan, Navera Ahmed, Ross Apostolov, Paul J Gow, Adam G Testro, Ed J Gane, Peter W Angus
Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation. JGH open : an open access journal of gastroenterology and hepatology 2 (6) (2018)
Abhinav Vasudevan, Ajay Raghunath, Shane Anthony, Cian Scanlon, Miles P Sparrow, Peter R Gibson, Daniel R van Langenberg
Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease. Digestive diseases and sciences 64 (6) (2018)